Paclitaxel News and Research

RSS
Paclitaxel is a drug used to treat breast cancer, ovarian cancer, and AIDS-related Kaposi sarcoma. It is also used together with another drug to treat non-small cell lung cancer. Paclitaxel is also being studied in the treatment of other types of cancer. It blocks cell growth by stopping cell division and may kill cancer cells. It is a type of antimitotic agent. Also called Taxol.

The Paclitaxel compound is extracted from the Pacific yew tree Taxus brevifolia with antineoplastic activity. Paclitaxel binds to tubulin and inhibits the disassembly of microtubules, thereby resulting in the inhibition of cell division. This agent also induces apoptosis by binding to and blocking the function of the apoptosis inhibitor protein Bcl-2 (B-cell Leukemia 2). Check for active clinical trials or closed clinical trials using this agent.
Good results in new lung cancer treatment

Good results in new lung cancer treatment

Stent trial fails to meet endpoints

Stent trial fails to meet endpoints

Launch date announced for Abraxane to treat metastatic breast cancer

Launch date announced for Abraxane to treat metastatic breast cancer

Abraxane, first in a new class of albumin-bound nanotechnology for the treatment of metastatic breast cancer

Abraxane, first in a new class of albumin-bound nanotechnology for the treatment of metastatic breast cancer

FDA approves Abraxane for metastatic breast cancer

FDA approves Abraxane for metastatic breast cancer

Paclitaxel may benefit Alzheimer's and Parkinson's movement disorders

Paclitaxel may benefit Alzheimer's and Parkinson's movement disorders

Cancer drug paclitaxel may reduce the adverse effects of Alzheimer's disease

Cancer drug paclitaxel may reduce the adverse effects of Alzheimer's disease

FDA approves Tarceva (erlotinib)

FDA approves Tarceva (erlotinib)

FDA fast tracks investigational anti-cancer drug, phenoxodiol

FDA fast tracks investigational anti-cancer drug, phenoxodiol

CA125 blood test may be superior to standard imaging techniques like CT scans

CA125 blood test may be superior to standard imaging techniques like CT scans

More women are surviving advanced breast cancer

More women are surviving advanced breast cancer

Drug-eluting stents (DES), increasingly used in coronary angioplasty, have benefits over bare-metal stents

Drug-eluting stents (DES), increasingly used in coronary angioplasty, have benefits over bare-metal stents

A drug derived from an ocean-growing sponge helps prevent the growth of cancer cells

A drug derived from an ocean-growing sponge helps prevent the growth of cancer cells

European Commission has approved the use of Herceptin® (trastuzumab) in combination with Taxotere®

European Commission has approved the use of Herceptin® (trastuzumab) in combination with Taxotere®

Genetically engineering viruses to carry a suicide gene into ovarian cancer cells

Genetically engineering viruses to carry a suicide gene into ovarian cancer cells

Paclitaxel analog kills more cancer cells than natural product

Paclitaxel analog kills more cancer cells than natural product

Investigational drug Abraxane is active and well tolerated in women with metastatic breast cancer

Investigational drug Abraxane is active and well tolerated in women with metastatic breast cancer

Gemcitabine/paclitaxel combination helps breast cancer patients live longer

Gemcitabine/paclitaxel combination helps breast cancer patients live longer

Chemotherapy regimen more effective and more toxic in Japanese patients than in American patients

Chemotherapy regimen more effective and more toxic in Japanese patients than in American patients

Herceptin shows real promise in treatment of HER-2 positive breast disease

Herceptin shows real promise in treatment of HER-2 positive breast disease